Skip to main content

Table 3 Organ equivalent doses and contribution to effective doses coefficient

From: Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB1

Organs h (male)
(µSv/MBq)
h (female)
(µSv/MBq)
Adrenals 4.4 5.9
Brain 6.2 8.1
Breasts 2.4
Esophagus 2.7 3.6
Gallbladder Wall 4.3 4.1
Left colon 2.8 3.6
Small Intestine 2.9 3.4
Stomach Wall 6.1 10.5
Right colon 2.8 3.4
Rectum 3.7 4.1
Heart Wall 6.9 9.1
Kidneys 10.5 12.9
Liver 11.9 11.3
Lungs 4.7 7.0
Ovaries 3.5
Pancreas 14.3 22.6
Prostate 4.5
Salivary Gland 2.1 2.8
Bone Marrow 3.9 4.6
Osteogenic Cells 3.1 3.4
Spleen 10.5 14.6
Testes 2.2
Thymus 2.3 3.4
Thyroid 6.3 8.3
Urin. Bladder Wall 53.6 22.3
Uterus 4.2
Remainder of Body 2.7 3.5
Effective Dose coefficient
(µSv/MBq)
6.0
  1. The organ equivalent dose coefficient h in µSv/MBq of each organ and the effective dose coefficient in µSv/MBq were calculated with OLINDA/EXM